Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

/C O R R E C T I O N -- GCCL/

In the news release, "GCCL Strengthens Asia-Pacific Presence at Asia Bio Partnering Forum 2026," issued on September 8, 2026 by GCCL over PR Newswire, we are advised by the company that the name "Yoo-Hwa Choi" should read "Yuhwa Choi" throughout the release, as originally issued inadvertently. Co...

2026-09-08 16:05 1734

PT Prodia Diacro Laboratories Receives Frost & Sullivan's 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition for Customer-Centric Clinical Research Excellence

Prodia the CRO is recognized for its reliable, integrated clinical research ecosystem, customer-centric delivery model, and commitment to quality, innovation, and long-term sponsor value across Southeast Asia. SAN ANTONIO, Sept. 8, 2026 /PRNewswire/ -- Frost & Sullivan

2026-09-08 13:00 1157

Taiwan's HORIEN Accelerates Global Footprint: Achieves Three Thai FDA Class 4 Approvals and Secures U.S. Patent for Biodegradable Ureteral Stent

Market-entry initiative targets qualified Thai distributors across dental, surgical, wound-care, and regenerative medicine channels, while solidifying global IP leadership in advanced urological biomaterials. TAICHUNG, Sept. 8, 2026 /PRNewswire/ -- HORIEN Biochemical Technology Co., Ltd. (TPEx: ...

2026-09-08 10:00 2588

Taiwan's HORIEN Accelerates Global Footprint: Achieves Three Thai FDA Class 4 Approvals and Secures U.S. Patent for Biodegradable Ureteral Stent

Huawei and Partners Jointly Launch Four AI+ Healthcare Scenarios Solution across APAC

SINGAPORE, Sept. 7, 2026 /PRNewswire/ -- HIMSS26 APAC a flagship digital health event for the Asia-Pacific region at Marina Bay Sands Expo and Convention Centre in Singapore. During the event, Huawei hosted the"AI for Health, Health for All" forum, bringing together more than 100 healthcare leade...

2026-09-08 09:00 2072

Huawei and Partners Jointly Launch Four AI+ Healthcare Scenarios Solution across APAC

Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds

Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia. SHANGHAI, Sept. 7, 2026 /PRNewswire/ -- On September 7, 2026, Shanghai, Cell Stem Cell published online clini...

2026-09-08 08:00 1341

Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds

U.S. District Court Invalidates Kaneka's Ubiquinol Patent, Clearing the Way for Cocrystal Tech's CrysQnol™ in the U.S. Market

Judge Overturns Kaneka's '080 Patent for Lack of Utility and Enablement, Removing Legal Uncertainty for Customers and Partners JIAXING, China, Sept. 7, 2026 /PRNewswire/ -- Cocrystal Technology (Jiaxing) Co., Ltd. ("Cocrystal Tech")today announced that the U.S. District Court for the Eastern Dis...

2026-09-07 20:30 3462

Ministry of Food and Drug Safety of Korea, Successfully Concludes 'GBC 2026,' Marking a Great Leap in Bio

– 5,600 participants from 19 countries discuss global bio innovation and the path forward – – Strengthened global regulatory cooperation, with a total of 23 meetings held with overseas regulators and industry, including 5 regulatory cooperation meetings – SEOUL, South Korea, Sept. 7, 2026 /PRNe...

2026-09-07 20:00 2711

Costa Rica Turns Its Reputation into Global Business Opportunities

* RepCore® Nations 2026 ranks Costa Rica 2.3 points above the average score of the world's 60 largest economies. SAN JOSÉ, Costa Rica, Sept. 7, 2026 /PRNewswire/ -- Coffee, bananas and biodiversity were among the first to put Costa Rica on the global map. Today, while they remain an essential p...

2026-09-07 20:00 1778

Costa Rica Turns Its Reputation into Global Business Opportunities

Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks

* First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment). * First Universal Consensus Across Six Independently-De...

2026-09-07 17:42 1939

AXA launches GBA EverGuard Medical Insurance meeting rising demand for cross-border healthcare

Delivers 100% full cover in Chinese mainland, Greater China flexibility for designated illnesses or major surgeries, and enhanced Traditional Chinese Medicine treatments and rehabilitation support HONG KONG, Sept. 7, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") today announced the launch...

2026-09-07 17:36 1314

CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities

YANTAI, China, Sept. 7, 2026 /PRNewswire/ -- CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achievedEXCiPACT™ GMP Certification for Pharmaceutical Auxiliary Materials (PAMs), becoming the first Chinese cell culture media supplier to r...

2026-09-07 14:00 1426

Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform

MELBOURNE, Australia, Sept. 7, 2026 /PRNewswire/ -- Nutromics, a Melbourne-based startup leading the frontier of DNA-based sensing, has announced the appointment of Professor Kevin W. Plaxco as Chief Scientific Officer (CSO). The company is preparing for the launch of its first product in 2027, ...

2026-09-07 13:14 1997

Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research

SEONGNAM, South Korea, Sept. 6, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in the high-efficiency production of circular RNA (circRNA) – a rapidly emerging modality ...

2026-09-07 12:36 1440

Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

HONG KONG, Sept. 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that, the ordinary shares of the Company (the "Shares"), which trade on The Stock Exchange of Hong Kong Limited (the "HK Stock Exchange"), have been included in the list of eligible securities under t...

2026-09-07 12:15 2301

Ddrops® Brings Medical Experts from Damansara Specialist Hospital and Motherhood.com.my Together in Malaysia for Science-Backed Vitamin D Forum

KUALA LUMPUR, Malaysia, Sept. 7, 2026 /PRNewswire/ -- Ddrops® brought together Damansara Specialist Hospital , recognised among the World's Best Hospitals (2026) powered by Statista, and Motherhood.com.my

2026-09-07 12:00 2473

Ddrops® Brings Medical Experts from Damansara Specialist Hospital and Motherhood.com.my Together in Malaysia for Science-Backed Vitamin D Forum

AIA Australia, Long Service Corporation, New Zealand Police and RMBL Investments Named 2026 Appian APJ Innovation Award Winners

Four organisations recognised for transforming mission-critical operations through process and AI SYDNEY, Sept. 7, 2026 /PRNewswire/ -- Appian [Nasdaq: APPN] today announced AIA Australia, Long Service Corporation New South Wales (NSW), New Zealand Policeand RMBL Investments as the winners of it...

2026-09-07 11:28 5638

AIA Australia, Long Service Corporation, New Zealand Police and RMBL Investments Named 2026 Appian APJ Innovation Award Winners

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand, Sept. 6, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today ann...

2026-09-07 08:46 1816

CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients

- First to demonstrate clinical utility of ring-type BP monitoring in AF and heart failure patients - Highlighted CART blood pressure monitor's multifaceted value, including ESH-based validation and sleep apnea tracking MUNICH and SEOUL, South Korea, Sept. 7, 2026 /PRNewswire/ -- Sky Labs (CEO J...

2026-09-07 08:00 1391

CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Robust neutralizing a...

2026-09-07 07:07 2128

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 6, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion. The share...

2026-09-07 07:00 4100

1 234 5 6 ... 849